K
13.04
-0.05 (-0.38%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | KalVista Pharmaceuticals, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.9
| 分析师共识 | 5.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.90 |
|
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 1.36% |
| 机构持股比例 | 113.44% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (Jones Trading, 130.06%) | 购买 |
| 中 | 28.00 (114.72%) | |
| 低 | 19.00 (Citizens Capital Markets, 45.71%) | 购买 |
| 平均值 | 25.67 (96.86%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 11.49 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Needham | 08 Apr 2025 | 28.00 (114.72%) | 购买 | 10.32 |
| 26 Mar 2025 | 28.00 (114.72%) | 购买 | 12.07 | |
| Citizens Capital Markets | 26 Mar 2025 | 19.00 (45.71%) | 购买 | 12.07 |
| Jones Trading | 26 Mar 2025 | 30.00 (130.06%) | 购买 | 12.07 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| PALLEIKO BENJAMIN L | - | 14.76 | -7,169 | -105,814 |
| 累积净数量 | -7,169 | |||
| 累积净值 ($) | -105,814 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 14.76 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PALLEIKO BENJAMIN L | 职员 | 09 Jun 2025 | 卖 (-) | 7,169 | 14.76 | 105,814 |
| PALLEIKO BENJAMIN L | 职员 | 06 Jun 2025 | 执行期权 | 15,625 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合